Elena Foster, MD
Vascular Surgery · Manchester, NHNPI 1053678326
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $65,963 of the $76,649 with a category attached, or 86.1%. Abbott accounts for 95.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $44,621 and has fallen 99.5% since, to $201 in 2025. Among vascular surgery clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $995.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$73K
- Silk Road Medical, Inc.$2K
- Terumo Medical Corporation$258
- W. L. Gore & Associates, Inc.$148
- Medtronic$132
- Tactile Systems Technology Inc$128
- plus $373 from 10 others
What the payments were for
- Consulting fees$65,96386%
- Speaking & faculty fees$4751%
- Travel & lodging$7,0979%
- Food & beverage$3,1154%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 37 | $73,491 |
| Silk Road Medical, Inc. | 12 | $2,119 |
| Terumo Medical Corporation | 3 | $258 |
| W. L. Gore & Associates, Inc. | 4 | $148 |
| Medtronic(2 entities) | 2 | $132 |
| Tactile Systems Technology Inc | 4 | $128 |
| Cook Medical LLC | 2 | $69 |
| Johnson & Johnson | 2 | $57 |
| Bard Peripheral Vascular, Inc. | 3 | $52 |
| Stryker | 1 | $48 |
| Boston Scientific | 2 | $35 |
| Shockwave Medical, Inc | 1 | $31 |
| Pfizer | 1 | $30 |
| KCI USA, Inc. | 1 | $22 |
| Penumbra, Inc. | 1 | $17 |
| Cardiva Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnilink Elite vascular stent system$29,439
- SUPERA$23,445
- OMNILINK ELITE$13,972
- PERCLOSE PROGLIDE$5,700
- ENROUTE Transcarotid Neuroprotection System$2,091
- ENHANCE Transcarotid Peripheral Access Kit$1,161
- ENROUTE Transcarotid Stent System$1,018
- ENROUTE 0.014 Guidewire$1,018
- ENROUTE Transcarotid Stent$965
- Navicross$209
- Glidesheath$209
- GlideWire$209
- ENROUTE .014 Guidewire$143
- Supera peripheral stent system$129
- VenaSeal$111
- MitraClip System$110
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$108
How this compares
$76,649 in reported general payments places this provider in the 95th percentile of 43 vascular surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $33,235 |
| XareltoRivaroxaban | 36 | $26,202 |
| Cilostazol | 29 | $385 |
| Atorvastatin Calcium | 35 | $330 |
| Rosuvastatin Calcium | 16 | $36 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $30 | $33,23534 claims |
| Johnson & JohnsonXarelto | $57 | $26,20236 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 43 vascular surgery providers in New Hampshire.
Other vascular surgery in Manchester
- Laurence YoungManchester$4K
- Griffin BollManchester$3K
- Robert AbduManchester$2K
- Chelsey LewisManchester$2K
- Bjoern SuckowLebanon$101K
- Mark FillingerLebanon$26K
- Matthew AlefLebanon$25K
- Richard PowellLebanon$19K
- Syed PeeranPortsmouth$15K
- David KuwayamaLebanon$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.